Colossal Biosciences

About

Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics.

Dallas,Texas,United States
https://colossal.com/

Highlights

Details

Last Funding Type: Series A
Last Funding Money Raised: $60M
Industries: Biotechnology,Genetics,Life Science
Founded date: Feb 4, 2021
Operating Status: Active
Legal Name: Colossal Biosciences, Inc.
Also Known As: Colossal

Colossal creates disruptive technologies for extinct species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. The company is the first to apply CRISPR technology for the purposes of species de-extinction, beginning with the woolly mammoth. Colossal is accepting humanity’s duty to restore Earth to a healthier state, while also solving for the future economies and biological necessities of the human condition through cutting-edge science and technologies.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

3

$75M

Colossal Biosciences has raised a total of $75M in funding over 2 rounds. Their latest funding was raised on Oct 3, 2022 from a Series Unknown round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Oct 3, 2022	Series Unknown	—	1	In-Q-Tel	—	Detail
Mar 9, 2022	Series A	$60M	19	At One Ventures Thomas Tull	—	Detail
May 6, 2021	Seed	$15M	17	Thomas Tull	—	Detail

Investments

Number of Investments

Number of Lead Investments

4

1

Colossal Biosciences has made 4 investments. Their most recent investment was on Dec 5, 2022, when Runway raised $50M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Dec 5, 2022 Runway	Series C	$50M	Artificial Intelligence	—
Dec 5, 2022 Twelve Labs	Seed	$12M	Information Technology	—
Jan 22, 2020 Front	Series C	$59M	Collaboration	Yes
Jun 17, 2019 Clockwise	Series A	$11.30M	Enterprise Software	—

Investors

Number of Lead Investors

Number of Investors

4

29

Colossal Biosciences is funded by 29 investors. In-Q-Tel and At One Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
In-Q-Tel	Yes	Series Unknown
At One Ventures	Yes	Series A
Thomas Tull	Yes	Series A
11:11 Media	—	Series A
Animal Capital	—	Series A
Animoca Brands	—	Series A
Bold Capital Partners	—	Series A
Boost VC	—	Series A
Breyer Capital	—	Series A
Builders VC	—	Series A